1-3 of 3
Elisa Brighenti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Free
Ilaria Iacobucci, PhD, Federica Cattina, MD, Silvia Pomella, Annalisa Lonetti, Enrico Derenzini, MD, Elisa Brighenti, Anna Ferrari, Cristina Papayannidis, Maria Vittoria Verga Falzacappa, Viviana Guadagnuolo, Michela Aluigi, PhD, Emanuela Ottaviani, Serena Formica, Maria Chiara Abbenante, Simona Soverini, Domenico Russo, Fabrizio Pane, Pier Guiseppe Pellicci, Michele Baccarani, MD, Giovanni Martinelli
Journal: Blood
Blood (2011) 118 (21): 76.
https://doi.org/10.1182/blood.V118.21.76.76
Published: 2011
Journal Articles

The Small Molecule JAK1/JAK2 Inhibitor INCB16562 Shows Single Agent Activity and Strongly Synergizes with Bcl-2 Inhibitors in Lymphoma

Free
Enrico Derenzini, MD, Manuela Lemoine, PhD, Elisa Brighenti, PhD, Richard Eric Davis, MD, Pier Luigi Zinzani, MD, Anas Younes, MD
Journal: Blood
Blood (2011) 118 (21): 2731.
https://doi.org/10.1182/blood.V118.21.2731.2731
Published: 2011
Journal Articles

The Small Molecule CHK1/CHK2 Inhibitor PF-0477736 (Pfizer) Demonstrates Single Agent Activity and Synergizes with Chemotherapy in Diffuse Large B-Cell Lymphoma

Free
Enrico Derenzini, MD, Ilaria Iacobucci, PhD, Elisa Brighenti, PhD, Federica Cattina, MD, Richard Eric Davis, MD, Stefano Pileri, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2011) 118 (21): 2732.
https://doi.org/10.1182/blood.V118.21.2732.2732
Published: 2011